Related Experiment Video
Updated: Nov 24, 2025

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs
Chenglong Chen1, Lu Xie2, Tingting Ren1
1Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing, 100044, People's Republic of China; Beijing Key Laboratory of Musculoskeletal Tumor, Beijing, People's Republic of China.
Osteosarcoma immunotherapy shows promise for treating bone cancer, even in advanced stages. Recent advances in immune response understanding and biomarker development are paving the way for new treatments.
Area of Science:
- Oncology
- Immunology
- Bone Cancer Research
Background:
- Osteosarcoma (OS) is the most common primary bone cancer.
- Metastatic or recurrent OS has a poor prognosis despite surgery and chemotherapy.
- Immunotherapy offers a promising strategy for treating various cancers.
Purpose of the Study:
- To review recent advances in osteosarcoma immunotherapy.
- To discuss the mechanisms and current status of OS immunotherapies.
- To explore future therapeutic directions for osteosarcoma.
Main Methods:
- Literature review of preclinical and clinical studies on osteosarcoma immunotherapy.
- Analysis of immune response mechanisms in osteosarcoma.
- Examination of biomarker development in OS immunotherapy.
Main Results:
- Immunotherapy is a rapidly advancing field for osteosarcoma treatment.
- Improved understanding of immune responses and biomarkers enhances patient benefit.
- Preclinical and clinical trials show potential for novel immunotherapeutic approaches.
Conclusions:
- Recent advances in immunotherapy hold significant promise for osteosarcoma patients.
- Further research into immune mechanisms and biomarkers is crucial.
- Novel immunotherapies may offer new hope for patients with advanced or recurrent osteosarcoma.
Related Concept Videos
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

